Objective: Laryngopharyngeal reflux (LPR) is defined as a retrograde flow of gastric contents into the larynx and hypopharynx. However, a possible pathophysiological contribution from nasal resistance has been proposed, according to which increased nasal resistance associated with septal deviation may cause increased respiratory effort, resulting in a more negative intrathoracic pressure, which may, in turn, overcome the upper esophageal sphincter and lead to the retrograde passage of gastric contents. The aim of this study was to investigate whether septal deviation of adequate severity necessitating septoplasty is associated with an increased use of proton pump inhibitors (PPIs) in comparison with the general population.
Material and Methods: This retrospective single-center cohort study investigated the usage of PPIs in patients undergoing septoplasty. Hospital databases were searched to identify patients aged 18-85 years who underwent septoplasty from January 2012 to December 2016. Electronic medical records were reviewed to collect details pertaining to demographic variables, usage of PPIs, smoking and drinking status, and other comorbidities. A control group of subjects who underwent an unrelated procedure (arthroscopy) was also sampled.
Results: The data of 200 patients (29% females, mean age 40.8±14.8 years) who underwent septoplasties were compared with those of 200 control subjects (39.5% females, mean age 45.3±15.0 years) who underwent arthroscopies. The incidence of PPI usage in patients undergoing septoplasty was found to be significantly greater than that in the control group (Pearson’s chi-square 4.7, Odds Ratio [OR] 1.97, p=0.03).
Conclusion: Patients who undergo septoplasty have a significantly increased rate of PPI usage, which suggests that nasal obstruction is associated with LPR and gastroesophageal reflux disease. Further studies are required to explore this association and develop potential therapeutic strategies.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Original Article |
| Authors | |
| Publication Date | April 1, 2020 |
| Published in Issue | Year 2020 Volume: 3 Issue: 1 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.